Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $301.36 | 13 | 88.3% |
| Education | $39.95 | 1 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $163.58 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $59.03 | 4 | $0 (2017) |
| Genentech USA, Inc. | $42.00 | 3 | $0 (2017) |
| Genentech, Inc. | $39.95 | 1 | $0 (2019) |
| Horizon Pharma plc | $36.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $39.95 | 1 | Genentech, Inc. ($39.95) |
| 2018 | $63.71 | 3 | Horizon Pharma plc ($36.75) |
| 2017 | $237.65 | 10 | AbbVie, Inc. ($136.62) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2019 | Genentech, Inc. | Rituxan (Biological) | Education | In-kind items and services | $39.95 | General |
| Category: BioOncology/Immunology | ||||||
| 09/10/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Immunology | ||||||
| 06/21/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: KRYSTEXXA | ||||||
| 01/15/2018 | AbbVie, Inc. | Humira (Biological), Humira, Humira | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Immunology | ||||||
| 12/05/2017 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $11.28 | General |
| Category: Immunology | ||||||
| 10/26/2017 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: BioOncology/Immunology | ||||||
| 10/17/2017 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Immunology | ||||||
| 08/30/2017 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: BioOncology/Immunology | ||||||
| 08/07/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Immunology | ||||||
| 06/28/2017 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: BioOncology/Immunology | ||||||
| 05/18/2017 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: Immunology | ||||||
| 04/04/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: Immunology | ||||||
| 03/14/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/07/2017 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 72 | 183 | $32,580 | $12,505 |
| 2020 | 2 | 87 | 168 | $33,854 | $9,962 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 45 | 131 | $27,231 | $9,019 | 33.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 27 | 52 | $5,349 | $3,486 | 65.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 64 | 134 | $30,458 | $7,954 | 26.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 23 | 34 | $3,396 | $2,008 | 59.1% |
About Dr. Robert Sylvester, M.D
Dr. Robert Sylvester, M.D is a Rheumatology healthcare provider based in Presque Isle, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992728042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sylvester, M.D has received a total of $341.31 in payments from pharmaceutical and medical device companies, with $39.95 received in 2019. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($301.36).
As a Medicare-enrolled provider, Sylvester has provided services to 159 Medicare beneficiaries, totaling 351 services with total Medicare billing of $22,467. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Presque Isle, ME
- Active Since 07/26/2006
- Last Updated 05/22/2017
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992728042
Products in Payments
- Rituxan (Biological) $81.95
- ORENCIA (Biological) $59.03
- Humira (Biological) $38.58
- KRYSTEXXA (Drug) $36.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.